Antibody discovery puts universal flu vaccine on horizon; Sinovac Biotech gains GMP certification for mumps vaccine plant in China;

> Protein Potential and Aduro BioTech team up to develop two malaria vaccines that will be administered in a sequential regimen. Release

> Sinovac Biotech received a GMP certification from the China State Food and Drug Administration for the company's mumps vaccine production plant. Release

> Pregnant women struggle to find a flu vaccine because many obstetricians don't offer the shot. Story

> Immune Targeting Systems announced positive Phase I data for its pan-strain influenza A T-cell vaccine. News

> Nonmedical vaccination opt-outs are on the rise in the U.S. Article

And Finally... An antibody discovery could put a universal flu vaccine on the horizon. Item

Suggested Articles

GSK's Shingrix has generated blockbuster sales early in the launch, but there's a lot of remaining opportunity, an exec said at JPM.

Quickly after Merck's world-first Ebola vaccine approval in Europe, U.S. authorities licensed the shot.

In an effort to stop an Ebola outbreak that has claimed 2,200 lives at the Rwanda border, J&J is shipping 200,000 doses of its vaccine to the country.